RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mohammad Tabatabai to Analgesics, Opioid

Back to Details
This is a "connection" page, showing publications Mohammad Tabatabai has written about Analgesics, Opioid.
Mohammad Tabatabai
Connection Strength
0.391
Analgesics, Opioid
  1. Cooper RL, Edgerton RD, Watson J, Conley N, Agee WA, Wilus DM, MacMaster SA, Bell L, Patel P, Godbole A, Bass-Thomas C, Ramesh A, Tabatabai M. Meta-analysis of primary care delivered buprenorphine treatment retention outcomes. Am J Drug Alcohol Abuse. 2023 11 02; 49(6):756-765.
    View in: PubMed
    Score: 0.201
  2. Tabatabai M, Cooper RL, Wilus DM, Edgerton RD, Ramesh A, MacMaster SA, Patel PN, Singh KP. The Effect of Naloxone Access Laws on Fatal Synthetic Opioid Overdose Fatality Rates. J Prim Care Community Health. 2023 Jan-Dec; 14:21501319221147246.
    View in: PubMed
    Score: 0.190
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support